• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能激动剂沙丁胺醇调节人类重症肌无力综合征斑马鱼模型中的神经肌肉接头形成。

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes.

机构信息

Institute of Genetic Medicine, The John Walton Muscular Dystrophy Research Centre, Newcastle University, International Centre for Life, Newcastle Upon Tyne NE1 3BZ, UK.

Tissue Omics Project Group, Biomedical Research Department, Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., 44227 Dortmund, Germany.

出版信息

Hum Mol Genet. 2018 May 1;27(9):1556-1564. doi: 10.1093/hmg/ddy062.

DOI:10.1093/hmg/ddy062
PMID:29462491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5905648/
Abstract

Inherited defects of the neuromuscular junction (NMJ) comprise an increasingly diverse range of disorders, termed congenital myasthenic syndromes (CMS). Therapies acting on the sympathetic nervous system, including the selective β2 adrenergic agonist salbutamol and the α and β adrenergic agonist ephedrine, have become standard treatment for several types of CMS. However, the mechanism of the therapeutic effect of sympathomimetics in these disorders is not understood. Here, we examined the effect of salbutamol on NMJ development using zebrafish with deficiency of the key postsynaptic proteins Dok-7 and MuSK. Treatment with salbutamol reduced motility defects in zebrafish embryos and larvae. In addition, salbutamol lead to morphological improvement of postsynaptic acetycholine receptor (AChR) clustering and size of synaptic contacts in Dok-7-deficient zebrafish. In MuSK-deficient zebrafish, salbutamol treatment reduced motor axon pathfinding defects and partially restored the formation of aneural prepatterned AChRs. In addition, the effects of salbutamol treatment were prevented by pre-treatment with a selective β2 antagonist. Treatment with the cyclic adenosine monophosphate (cAMP) activator forskolin, replicated the effects of salbutamol treatment. These results suggest that sympathomimetics exert a direct effect on neuromuscular synaptogenesis and do so via β2 adrenoceptors and via a cAMP-dependent pathway.

摘要

神经肌肉接头(NMJ)的遗传缺陷包括越来越多样化的疾病,称为先天性肌无力综合征(CMS)。作用于交感神经系统的治疗方法,包括选择性β2 肾上腺素能激动剂沙丁胺醇和α和β肾上腺素能激动剂麻黄碱,已成为几种 CMS 的标准治疗方法。然而,这些疾病中拟交感神经药物治疗效果的机制尚不清楚。在这里,我们使用缺乏关键突触后蛋白 Dok-7 和 MuSK 的斑马鱼研究了沙丁胺醇对 NMJ 发育的影响。沙丁胺醇处理可减少斑马鱼胚胎和幼虫的运动缺陷。此外,沙丁胺醇导致 Dok-7 缺陷的斑马鱼中突触后乙酰胆碱受体(AChR)聚集和突触接触大小的形态改善。在 MuSK 缺陷的斑马鱼中,沙丁胺醇处理可减少运动轴突寻径缺陷,并部分恢复无神经预先形成的 AChR 的形成。此外,β2 受体选择性拮抗剂的预处理可预防沙丁胺醇处理的作用。环磷酸腺苷(cAMP)激活剂 forskolin 的处理复制了沙丁胺醇处理的效果。这些结果表明,拟交感神经药物对神经肌肉突触发生有直接作用,通过β2 肾上腺素能受体和 cAMP 依赖性途径发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/f59fb9e62436/ddy062f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7595e4906374/ddy062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/889b60f79f4b/ddy062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7ce562df7a3c/ddy062f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7e0987b37d77/ddy062f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/f59fb9e62436/ddy062f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7595e4906374/ddy062f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/889b60f79f4b/ddy062f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7ce562df7a3c/ddy062f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/7e0987b37d77/ddy062f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf0/5905648/f59fb9e62436/ddy062f5.jpg

相似文献

1
The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes.β-肾上腺素能激动剂沙丁胺醇调节人类重症肌无力综合征斑马鱼模型中的神经肌肉接头形成。
Hum Mol Genet. 2018 May 1;27(9):1556-1564. doi: 10.1093/hmg/ddy062.
2
Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.多巴受体激酶 7 型先天性肌无力症小鼠模型中沙丁胺醇对神经肌肉接头功能和结构的影响。
Hum Mol Genet. 2020 Aug 11;29(14):2325-2336. doi: 10.1093/hmg/ddaa116.
3
β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.β2-肾上腺素受体激动剂可改善长期吡啶斯的明对神经肌肉接头结构的不良影响。
Brain. 2019 Dec 1;142(12):3713-3727. doi: 10.1093/brain/awz322.
4
Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.沙丁胺醇修饰 ColQ 肌无力综合征小鼠模型中的神经肌肉接头。
Hum Mol Genet. 2019 Jul 15;28(14):2339-2351. doi: 10.1093/hmg/ddz059.
5
Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.β2 肾上腺素受体激动剂增强 C2C12 肌管中 AChR 的聚集:对重症肌无力治疗的启示。
J Neuromuscul Dis. 2018;5(2):231-240. doi: 10.3233/JND-170293.
6
Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.Dok-7 可促进先天性肌无力综合征斑马鱼模型中的慢肌完整性和神经肌肉接头形成。
Hum Mol Genet. 2010 May 1;19(9):1726-40. doi: 10.1093/hmg/ddq049. Epub 2010 Feb 10.
7
Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.遗传性运动神经病中的神经肌肉接头受累:遗传异质性和口服沙丁胺醇治疗的效果。
J Neurol. 2023 Jun;270(6):3112-3119. doi: 10.1007/s00415-023-11643-z. Epub 2023 Mar 4.
8
Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.DOK7 突变导致的先天性肌无力综合征的沙丁胺醇治疗。
J Neurol Sci. 2013 Aug 15;331(1-2):155-7. doi: 10.1016/j.jns.2013.05.017. Epub 2013 Jun 19.
9
Dok-7/MuSK signaling and a congenital myasthenic syndrome.Dok-7/MuSK信号传导与先天性肌无力综合征。
Acta Myol. 2008 Jul;27(1):25-9.
10
Influence of β-adrenergic selective agonist formoterol on the motor unit of a mouse model of a congenital myasthenic syndrome with complete VAChT deletion.β-肾上腺素能选择性激动剂福莫特罗对完全缺失 VAChT 的先天性肌无力综合征小鼠模型运动单位的影响。
Neuropharmacology. 2024 Dec 1;260:110116. doi: 10.1016/j.neuropharm.2024.110116. Epub 2024 Aug 14.

引用本文的文献

1
Adrenergic Modulation of Acetylcholine Release at the Mouse Neuromuscular Junctions of Fast-Twitch Skeletal Muscle.快速收缩骨骼肌小鼠神经肌肉接头处乙酰胆碱释放的肾上腺素能调节
Neurochem Res. 2025 May 12;50(3):162. doi: 10.1007/s11064-025-04415-w.
2
Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1 mouse model of collagen VI-related myopathies.在胶原蛋白VI相关肌病的Col6a1小鼠模型中,沙丁胺醇的新用途改善了神经肌肉接头缺陷和肌肉萎缩。
Clin Transl Med. 2024 Jul;14(7):e1688. doi: 10.1002/ctm2.1688.
3
β2-Adrenergic Regulation of the Neuromuscular Transmission and Its Lipid-Dependent Switch.

本文引用的文献

1
Postnatal knockdown of dok-7 gene expression in mice causes structural defects in neuromuscular synapses and myasthenic pathology.小鼠出生后dok-7基因表达的敲低会导致神经肌肉突触的结构缺陷和肌无力病理改变。
Genes Cells. 2016 Jun;21(6):670-6. doi: 10.1111/gtc.12370. Epub 2016 Apr 18.
2
Sympathetic innervation controls homeostasis of neuromuscular junctions in health and disease.交感神经支配在健康和疾病状态下控制神经肌肉接头的稳态。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):746-50. doi: 10.1073/pnas.1524272113. Epub 2016 Jan 5.
3
Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
β2-肾上腺素能调控的神经肌肉传递及其脂质依赖性转换。
Mol Neurobiol. 2024 Sep;61(9):6805-6821. doi: 10.1007/s12035-024-03991-2. Epub 2024 Feb 14.
4
Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series.PTPN11 基因突变可导致先天性肌无力综合征表型:努南综合征病例系列研究。
J Neurol. 2024 Mar;271(3):1331-1341. doi: 10.1007/s00415-023-12070-w. Epub 2023 Nov 4.
5
Sympathetic neuropathology is revealed in muscles affected by amyotrophic lateral sclerosis.在受肌萎缩侧索硬化影响的肌肉中发现了交感神经病理学特征。
Front Physiol. 2023 May 12;14:1165811. doi: 10.3389/fphys.2023.1165811. eCollection 2023.
6
Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.遗传性运动神经病中的神经肌肉接头受累:遗传异质性和口服沙丁胺醇治疗的效果。
J Neurol. 2023 Jun;270(6):3112-3119. doi: 10.1007/s00415-023-11643-z. Epub 2023 Mar 4.
7
Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by Mutations.先天性肌营养不良症致药物治疗突变。
Curr Neuropharmacol. 2023;21(7):1594-1605. doi: 10.2174/1570159X21666230126145652.
8
2-Phenethylamines in Medicinal Chemistry: A Review.2-苯乙胺类化合物在药物化学中的研究进展:综述
Molecules. 2023 Jan 14;28(2):855. doi: 10.3390/molecules28020855.
9
Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases.开发一种用于斑马鱼的高通量定制成像方法,以了解和治疗神经肌肉疾病。
Front Mol Neurosci. 2022 Sep 20;15:956582. doi: 10.3389/fnmol.2022.956582. eCollection 2022.
10
Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome.在先天性肌无力综合征小鼠模型中,调节乙酰胆碱受体聚集途径可改善神经肌肉接头结构和肌肉力量。
Front Mol Neurosci. 2020 Dec 17;13:594220. doi: 10.3389/fnmol.2020.594220. eCollection 2020.
神经肌肉疾病。DOK7 基因治疗有益于神经肌肉接头缺陷疾病的小鼠模型。
Science. 2014 Sep 19;345(6203):1505-8. doi: 10.1126/science.1250744.
4
Alterations of cAMP-dependent signaling in dystrophic skeletal muscle.营养不良性骨骼肌中cAMP依赖性信号传导的改变。
Front Physiol. 2013 Oct 17;4:290. doi: 10.3389/fphys.2013.00290.
5
Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.DOK7 突变导致的先天性肌无力综合征的沙丁胺醇治疗。
J Neurol Sci. 2013 Aug 15;331(1-2):155-7. doi: 10.1016/j.jns.2013.05.017. Epub 2013 Jun 19.
6
Congenital myasthenic syndromes: an update.先天性肌无力综合征:最新进展
Pract Neurol. 2013 Apr;13(2):80-91. doi: 10.1136/practneurol-2012-000404.
7
Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.沙丁胺醇有益于 DOK7 突变导致的先天性肌无力综合征患儿。
Neuromuscul Disord. 2013 Feb;23(2):170-5. doi: 10.1016/j.nmd.2012.11.004. Epub 2012 Dec 5.
8
Wnt4 participates in the formation of vertebrate neuromuscular junction.Wnt4 参与脊椎动物神经肌肉接头的形成。
PLoS One. 2012;7(1):e29976. doi: 10.1371/journal.pone.0029976. Epub 2012 Jan 12.
9
Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.沙丁胺醇对先天性板层乙酰胆碱酯酶缺乏症和 Dok-7 肌无力的有益作用。
Muscle Nerve. 2011 Nov;44(5):789-94. doi: 10.1002/mus.22176. Epub 2011 Sep 23.
10
Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.Dok-7 通过招募 Crk 和 Crk-L 来调节神经肌肉突触的形成。
Genes Dev. 2010 Nov 1;24(21):2451-61. doi: 10.1101/gad.1977710.